Skip to content
AdminApr 27, 2022< 1 min read

Utility Assessments in Synthetic Data

2022-04-27-Utility-Assessments-in-Synthetic-Data

Lucy Mosquera, Director of Data Science, Replica Analytics

Xi Fang, Data Scientist, Replica Analytics

This webinar explores ways to assess utility in synthetic data and shares new research. We identify which utility assessments are most predictive of analytic value and show which can best rank synthesis methods for performance on a realistic biostatistics analysis. The study was funded by multiple Canadian government research funding agencies and the Bill and Melinda Gates Foundation.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

AdminOct 31, 20243 min read

Applying AI to RWE and Drug Development

With applications abound, AI is poised to change how RWD/RWE teams operate and how quickly they can accelerate drug ...
Start Reading
AdminOct 31, 20243 min read

What’s Next for Healthcare in 2025: Emerging Threats, GLP-1 Inhibitors, AI, and the Power of RWE

As 2024 comes to a close and 2025 gets going, major changes in healthcare and drug development loom. Emerging infectious ...
Start Reading
AdminOct 30, 20241 min read

Evaluating Real-World Use of Botulinum Toxins for Cervical Dystonia, Blepharospasm, and Hemifacial Spasm

Movement disorders like cervical dystonia, blepharospasm, and hemifacial spasm can greatly diminish the quality of life for ...
Start Reading